J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pulli, T.
Right arrow Articles by Hyypia, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pulli, T.
Right arrow Articles by Hyypia, T.
Agricola
Right arrow Articles by Pulli, T.
Right arrow Articles by Hyypia, T.

Journal of General Virology, Vol 79, 2249-2253, Copyright © 1998 by Society for General Microbiology

ARTICLES

Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1

T Pulli, M Roivainen, T Hovi and T Hyypia
Enterovirus Laboratory, National Public Health Institute, Helsinki, Finland. timo@pulli@ktl.fi

The arginine-glycine-aspartic acid motif at the C terminus of coxsackievirus A9 capsid protein VP1 has been shown to play a role in specific attachment of the virus to alpha(v)beta3 integrin on the host cell surface. The C-terminal region of the VP1 protein has also been shown to be highly antigenic by using peptide scanning techniques. To find out whether this region contains a neutralizing epitope, three overlapping peptides covering the C-terminal end of VP1 were synthesized and rabbit antisera were raised against these peptides. Neutralization of the virus was observed with all three antipeptide antisera in A549 cells and with two antisera in RD cells.


This article has been cited by other articles:


Home page
 J. Virol.Home page
N. Verdaguer, M. A. Jimenez-Clavero, I. Fita, and V. Ley
Structure of Swine Vesicular Disease Virus: Mapping of Changes Occurring during Adaptation of Human Coxsackie B5 Virus To Infect Swine
J. Virol., September 15, 2003; 77(18): 9780 - 9789.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
H. Harvala, H. Kalimo, G. Stanway, and T. Hyypia
Pathogenesis of coxsackievirus A9 in mice: role of the viral arginine-glycine-aspartic acid motif
J. Gen. Virol., September 1, 2003; 84(9): 2375 - 2379.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
H. Norder, L. Bjerregaard, L. Magnius, B. Lina, M. Aymard, and J.-J. Chomel
Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types
J. Gen. Virol., April 1, 2003; 84(4): 827 - 836.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. A. Jiménez-Clavero, E. Escribano-Romero, A. J. Douglas, and V. Ley
The N-Terminal Region of the VP1 Protein of Swine Vesicular Disease Virus Contains a Neutralization Site That Arises upon Cell Attachment and Is Involved in Viral Entry
J. Virol., January 15, 2001; 75(2): 1044 - 1047.
[Abstract] [Full Text]

Home page
 J. Gen. Virol.Home page
P. Joki-Korpela, M. Roivainen, H. Lankinen, T. Pöyry, and T. Hyypiä
Antigenic properties of human parechovirus 1
J. Gen. Virol., July 1, 2000; 81(7): 1709 - 1718.
[Abstract] [Full Text]

Home page
 J. Gen. Virol.Home page
J. Santti, H. Harvala, L. Kinnunen, and T. Hyypiä
Molecular epidemiology and evolution of coxsackievirus A9
J. Gen. Virol., May 1, 2000; 81(5): 1361 - 1372.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1998 by the Society for General Microbiology.